Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic disorders of metabolism.
Nasdaq: AGIO
    
Quarterly Results
Q4 2016 Earnings
Q3 2016 Earnings
Q2 2016 Earnings
Q1 2016 Earnings
Q4 2015 Earnings
Q3 2015 Earnings
Q2 2015 Earnings